본문 바로가기
KERD
논문KCI 등재

Developmental Neurotoxicity in vitro Screening Test Method that Measures Cell Viability and Proliferation using Human Neuroprogenitor Cells

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Current developmental neurotoxicity tests are based on in vivo tests, and many kinds of chemicals cannot be evaluated due to restrictions such as the number, cost, and time of animals used in the test. Recently, in vitro test methods for screening test chemicals that may damage the nervous system are being studied. As an alternative test for developmental neurotoxicity, an in vitro test method that measures the endpoint of neurogenesis process is being studied; however, a single in vitro assay cannot completely cover all neurogenesis processes. Therefore, studies are being carried out to combine test methods as endpoints for key events in neurogenesis process and test battery study. In this study, we used human neuroprogenitor cells, ReNcell™ CX, to evaluate developmental neurotoxicity of test substances on cell viability (MTT assay) and proliferation (BrdU assay) by ELISA method. This method has the advantage of being able to quickly and easily evaluates many substances compared to previous methods using fluorescence microscope. First, we tested to optimize the test method using known antiproliferative/ non-antiproliferative chemicals, we were able to obtain 100% accuracy compared to the previous study. This was verified by confirming that it was appropriate to evaluate cell viability and proliferation using a human neural progenitor cells (ReNcell™ CX). In the utilization study, 18 test substances were evaluated. As a result, 11 test substances (Acrylamide, Bisphenol A, Carbamazepine, Chlorpyrifos, Diethylstilbestrol, Perfluorooctanoic Acid, Sodium arsenite, 3,3’,5,5 ‘-Tetrabromobisphenol A, Ibuprofen, Omeprazole, and Verapamil) were judged as substances with developmental neurotoxicity potential, and 7 test substances (Di (2-ethylhexyl) phthalate, Fluconazole, Permethrin, Atropine, Captopril, D-Mannitol, and Dinotefuran) were judged as non-developmental neurotoxicity substances. The sensitivity was 70% (7/10), specificity 50% (4/8), accuracy 61% (11/18), false positive rate 50% (4/8), and false negative rate 30% (3/10). These results show that it can be used as an in vitro screening test for developmental neurotoxicity that can measure and evaluate many substances within a short time compared to the existing in vivo tests. In addition, this test is a single in vitro screening test, and further studies are needed to evaluate it in combination with other in vitro test method.

Abstract

Current developmental neurotoxicity tests are based on in vivo tests, and many kinds of chemicals cannot be evaluated due to restrictions such as the number, cost, and time of animals used in the test. Recently, in vitro test methods for screening test chemicals that may damage the nervous system are being studied. As an alternative test for developmental neurotoxicity, an in vitro test method that measures the endpoint of neurogenesis process is being studied; however, a single in vitro assay cannot completely cover all neurogenesis processes. Therefore, studies are being carried out to combine test methods as endpoints for key events in neurogenesis process and test battery study. In this study, we used human neuroprogenitor cells, ReNcell™ CX, to evaluate developmental neurotoxicity of test substances on cell viability (MTT assay) and proliferation (BrdU assay) by ELISA method. This method has the advantage of being able to quickly and easily evaluates many substances compared to previous methods using fluorescence microscope. First, we tested to optimize the test method using known antiproliferative/ non-antiproliferative chemicals, we were able to obtain 100% accuracy compared to the previous study. This was verified by confirming that it was appropriate to evaluate cell viability and proliferation using a human neural progenitor cells (ReNcell™ CX). In the utilization study, 18 test substances were evaluated. As a result, 11 test substances (Acrylamide, Bisphenol A, Carbamazepine, Chlorpyrifos, Diethylstilbestrol, Perfluorooctanoic Acid, Sodium arsenite, 3,3’,5,5 ‘-Tetrabromobisphenol A, Ibuprofen, Omeprazole, and Verapamil) were judged as substances with developmental neurotoxicity potential, and 7 test substances (Di (2-ethylhexyl) phthalate, Fluconazole, Permethrin, Atropine, Captopril, D-Mannitol, and Dinotefuran) were judged as non-developmental neurotoxicity substances. The sensitivity was 70% (7/10), specificity 50% (4/8), accuracy 61% (11/18), false positive rate 50% (4/8), and false negative rate 30% (3/10). These results show that it can be used as an in vitro screening test for developmental neurotoxicity that can measure and evaluate many substances within a short time compared to the existing in vivo tests. In addition, this test is a single in vitro screening test, and further studies are needed to evaluate it in combination with other in vitro test method.

참고문헌 (36)

  1. Coecke S, "Workgroup report : Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies", Environ. Health Perspect, 115, pp.924~931 (2007)
  2. Lein P, "Meeting report : Alternatives for developmental neurotoxicity testing", Environ. Health Perspect, 115, pp.764~768 (2007)
  3. NRC, "Toxicity Testing in the Twenty-First Century:A Vision and a Strategy" (2007), The National Academies Press
  4. Radio NM, "Use of Neural Models of Proliferation and Neurite Outgrowth to Screen Environmental Chemicals in the ToxCast Phase I Library", APPLIED IN VITRO TOXICOLOGY, 1(2) (2015)
  5. Breier JM, "Development of a High-Throughput Screening Assay for Chemical Effects on Proliferation and Viability of Immortalized Human Neural Progenitor Cells", TOXICOLOGICAL SCIENCES, 105(1), pp.119~133 (2008)
  6. Goldberg RL, "Effect of heavy metals on human rheumatoid synovial cell proliferation and collagen synthesis", Biochem. Pharmacol, 32, pp.2763~2766 (1983)
  7. Piersma AH, "Cadmium-induced inhibition of proliferation and differentiation of embryonal carcinoma cells and mechanistic aspects of protection by zinc", Teratology, 48, pp.335~341 (1993)
  8. Aguayo AJ, "Experimental necrocis and arrest of proliferation of Schwann cells by cytosine arabinoside", Journal of Neurocytology, 4, pp.663~674 (1975)
  9. Kizaki H, "1-beta-D-arabinosylcytosine and 5-azacytidine induce internucleosomal DNA fragmentation and cell death in thymocytes", Immunopharmacology, 24, pp.219~227 (1992)
  10. Larsen IK, "Characterization of the active site of ribonucleotide reductase of Escherichia coli, bacteriophage T4 and mammalian cells by inhibition studies with hydroxyurea analogues", Eur. J. Biochem, 125, pp.75~81 (1982)
  11. Imada T, "In vitro combination effect of 5-fluorouracil and cisplatin on the proliferation, morphology and expression of Ki-67 antigen in human gastric cancer cells", Anticancer Drugs, 8, pp.1000~1006 (1997)
  12. Desi I, "Behavioural and neurotoxicological changes caused by cadmium treatment of rats during development", J. Appl. Toxicol, 18, pp.63~70 (1998)
  13. Adlard BPF, "A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat", Br. J. Pharmacol, 54, pp.33~39 (1975)
  14. Woo GH, "Molecular mechanisms of hydroxyurea(HU)-induced apoptosis in the mouse fetal brain", Neuroteratol. Toxicol, 28, pp.125~134 (2006)
  15. Adams J, "Functional Neuroteratology of Short-Term Exposure to Drugs", pp.59~70 (1991), Teikyo University Press
  16. Kuwagata M, "A comparison of the in vivo and in vitro response of rat embryos to 5-fluorouricil", J. Vet. Med. Sci, 60, pp.93~99 (1998)
  17. Dietrich J, "CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo", J. Biol, 5, pp.22~ (2006)
  18. LoPresti P, "Neuronal differentiation triggered by blocking cell proliferation", Cell Growth Differ, 3, pp.627~635 (1992)
  19. Rajasingh J, "15-Deoxy-delta12, 14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAKSTAT pathway in mouse embryonic stem cells", Exp. Cell Res, 312, pp.2538~2546 (2006)
  20. Bogdahn U, "Therapy of malignant brain tumors:Comparison of the in vitro activities of vidarabinmonophosphate, BCNU and 5-fluorouracil", Acta Neurol. Scand, 75, pp.28~36 (1987)
  21. Ellenhorn MJ, "Ellenhorn’s Medical Toxicology: Diagnosis and Treatment of Human Poisoning", JAMA, 278(14) (1997), Williams and Wilkins
  22. Park JS, "Developmental and Neurotoxicity of Acrylamide to Zebrafish", Int. J. Mol. Sci, 22, pp.3518~ (2021)
  23. Kuruto-Niwa R, "Measurement of bisphenol A concentrations in human colostrum", Chemosphere, 66(6), pp.1160~1164 (2007)
  24. Report of Joint FAOWHO Expert Meeting, "Toxicological and Health Aspects of Bisphenol A", ~ (2010)
  25. McEvoy GK, "AHFS 2007 Drug Information Essentials", American Society of Health-System Pharmacists, Inc, 1139~1141 (2007)
  26. Kaplan JG, "Sensory neuropathy associated with Dursban (chlorpyrifos) exposure", Neurology, 43(11), pp.2193~2196 (1993)
  27. Amani N, "Chlorpyrifos Toxicity in Mouse Cultured Cerebellar Granule Neurons at Different Stages of Development: Additive Effect on Glutamate-Induced Excitotoxicity", CELL JOURNAL (Yakhteh), 18(3), pp.464~472 (2016)
  28. McEvoy, G.K, "AHFS 1999 Drug Information", American Society of Health-System Pharmacists, Inc, 265~306 (1999)
  29. Al Jishi T, "Current perspective of diethylstilbestrol exposure in mothers and offspring", Reproductive Toxicology, 71, pp.71~77 (2017)
  30. Quist EM, "Hepatic mitochondrial alteration in CD-1mice associated with prenatal exposures to low doses of perfluorooctanoic acid(PFOA)", Toxicol Pathol, 43, pp.546~557 (2015)
  31. Slotkin TA, "Developmental Neurotoxicity of Perfluorinated Chemicals Modeled in Vitro", Environmental Health Perspectives, 116(6), pp.716~722 (2008)
  32. Sun H, "Sodium Arsenite-Induced Learning and Memory Impairment Is Associated with Endoplasmic Reticulum Stress-Mediated Apoptosis in Rat Hippocampus", Frontiers in Molecular Neuroscience, 10 (2017)
  33. Lilienthal H, "Exposure to tetrabromobisphenol A(TBBPA)in Wistar rats : Neurobehavioral effects in offspring from a one-generation reproduction study", Toxicology, 246, pp.45~54 (2008)
  34. Kamour A, "Central nervous system toxicity of mefenamic acid overdose compared with other NSAIDs : an analysis of cases reported to the United Kingdom National Poisons Information Service", Br J Clin Pharmacol, 83, pp.855~862 (2016)
  35. Paz MFCJ, "Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer", Oxidative Medicine and Cellular Longevity, 2020, pp.21~ (2020)
  36. Passal DB, "Verapamil poisoning in an infant", Pedatrics, 73, pp.543~545 (1984)

관련 논문AI추천

이 간행물의 다른 논문 (6건)